Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Affiliations

• ¹ Barts Cancer Centre, Barts Health NHS Trust, Queen Mary University of London, London, UK.
• ² Beth Israel Deaconess Medical Centre-IMIM Lab, Harvard Medical School, Boston, USA.
• ³ L'Assistance Publique-Hôpitaux de Paris, Hôpital Tenon, Paris, France.
• ⁴ Department of Urology, Charité Universitätsmedizin, Berlin, Germany.
• ⁵ Royal Marsden Hospital, Institute of Cancer Research, London, UK.
• ⁶ Département de Médecine Oncologique, Université Paris-Saclay and Gustave Roussy, Villejuif, France.
• ⁷ Vita-Salute San Raffaele University, Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.
• ⁸ University Hospital Virgen del Rocio, Seville, Spain.
• ⁹ Hôpital Saint-André CHU, Bordeaux, France; Department of Medical Oncology, Bordeaux University Hospital, Bordeaux, France.
• ¹⁰ Department of Urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria.
• ¹¹ Barts Cancer Centre, Barts Health NHS Trust, Queen Mary University of London, London, UK; Department of Urology, University College London Hospital, London, UK.
• ¹² Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
• ¹³ Oncology Institute of Southern Switzerland (IOSI), EOC, Lugano, Switzerland.